HOFFMAN; Timothy Z.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HOFFMAN; Timothy Z..The latest application filed is for "antibody conjugates comprising toll-like receptor agonist".

Company Profile

4.11.19

HOFFMAN; Timothy Z. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Conjugates Comprising Toll-like Receptor Agonist App 20210346387 - CORTEZ; Alex ; et al.	2021-11-11
Antibody conjugates comprising toll-like receptor agonist Grant 10,973,826 - Cortez , et al. April 13, 2	2021-04-13
Antibody Conjugates Comprising Toll-like Receptor Agonist And Combination Therapies App 20200164084 - Cortez; Alex ; et al.	2020-05-28
Methods And Compositions For Ocular Cell Therapy App 20200131474 - BERENSHTEYN; Frada ; et al.	2020-04-30
Adsorption of immunopotentiators to insoluble metal salts Grant 10,098,949 - Singh , et al. October 16, 2	2018-10-16
Antibody Conjugates Comprising Toll-like Receptor Agonist App 20170121421 - CORTEZ; Alex ; et al.	2017-05-04
Adsorption Of Immunopotentiators To Insoluble Metal Salts App 20160213776 - SINGH; Manmohan ; et al.	2016-07-28
Compounds and compositions as TLR2 agonists Grant 9,365,506 - Wu , et al. June 14, 2	2016-06-14
Adsorption of immunopotentiators to insoluble metal salts Grant 9,315,530 - Singh , et al. April 19, 2	2016-04-19
Compounds And Compositions As Tlr2 Agonists App 20140323390 - WU; Tom Yao-Hsiang ; et al.	2014-10-30
Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc Grant 8,808,703 - Wu , et al. August 19, 2	2014-08-19
Adsorption Of Immunopotentiators To Insoluble Metal Salts App 20130274465 - Singh; Manmohan ; et al.	2013-10-17
Compounds (cystein Based Lipopeptides) And Compositions As Tlr2 Agonists Used For Treating Infections, Inflammations, Respiratory Diseases Etc. App 20130065861 - Wu; Tom Yao-Hsiang ; et al.	2013-03-14
Formulation of immunopotentiators App 20120177681 - Singh; Manmohan ; et al.	2012-07-12
Heterocyclic Modulators Of Tgr5 App 20090105124 - Smith; Nicholas D. ; et al.	2009-04-23
Quinazolinone Modulators Of Tgr5 App 20090035306 - Pinkerton; Anthony B. ; et al.	2009-02-05
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease Grant 7,470,722 - Malecha , et al. December 30, 2	2008-12-30
Sulfonamides as inhibitors of histone deacetylase for the treatment of disease Grant 7,381,749 - Malecha , et al. June 3, 2	2008-06-03
Inhibitors Of Histone Deacetylase For The Treatment Of Disease App 20070135431 - Smith; Nicholas D. ; et al.	2007-06-14
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease App 20070027184 - Malecha; James W. ; et al.	2007-02-01
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease App 20060030543 - Malecha; James William ; et al.	2006-02-09
Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease App 20060030554 - Malecha; James William ; et al.	2006-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.